Henric Blomgren
About
In The Last Decade
Henric Blomgren
263 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Immunology 2.4k
- Oncology 1.9k
- Pulmonary and Respiratory Medicine 1.6k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Radiation 1.2k
Countries citing papers authored by Henric Blomgren
This map shows the geographic impact of Henric Blomgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henric Blomgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henric Blomgren more than expected).
Fields of papers citing papers by Henric Blomgren
This network shows the impact of papers produced by Henric Blomgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henric Blomgren. The network helps show where Henric Blomgren may publish in the future.
Co-authorship network of co-authors of Henric Blomgren
This figure shows the co-authorship network connecting the top 25 collaborators of Henric Blomgren. A scholar is included among the top collaborators of Henric Blomgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henric Blomgren. Henric Blomgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 68 | |
| 3 | 55 | |
| 4 | 5 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | Release of a votile factor from solutions of oxazaphosphorines which damage normal and malignant cells. | 3 |
| 8 | 2 | |
| 9 | Augmentation of spontaneous cytotoxicity of human lymphocytes by RU 41.740 is due to monocyte-derived factors distinct from interleukin 2, interferon alpha and gamma. | 6 |
| 10 | 13 | |
| 11 | 10 | |
| 12 | 8 | |
| 13 | 4 | |
| 14 | 37 | |
| 15 | 11 | |
| 16 | Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I study. | 11 |
| 17 | 6 | |
| 18 | 8 | |
| 19 | 8 | |
| 20 | 154 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.